Semaglutide NAION Risk: EMA Review Initiated Am...

By João L. Carapinha

January 21, 2025

The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) is reviewing the potent...

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.